ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,631.22
0.28%
US Tech 100
19,871.20
0.40%
다우존스 지수
40,211.72
0.53%
Bitcoin
63,818.39
5.00%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Boundless Bio Inc (BOLD)

  7. Boundless Bio Inc (BOLD) 뉴스

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BOLD
일자시간출처헤드라인심볼기업
2018/08/0719:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2018/08/0719:12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BOLDBoundless Bio Inc
2018/08/0719:00PR Newswire (US)Audentes Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on ASPIRO, the Phase 1/2 Clinical Tri...NASDAQ:BOLDBoundless Bio Inc
2018/07/3121:00PR Newswire (US)Audentes to Release Second Quarter 2018 Financial Results and Provide Update on ASPIRO, the Phase 1/2 study of AT132 in Patie...NASDAQ:BOLDBoundless Bio Inc
2018/07/0607:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/07/0607:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/06/2807:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/06/2807:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/06/2308:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/06/0906:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/06/0906:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/06/0906:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/06/0906:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/06/0906:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/06/0906:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/06/0906:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/06/0906:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2018/06/0521:00PR Newswire (US)Audentes Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to AT132 for the treatment...NASDAQ:BOLDBoundless Bio Inc
2018/06/0505:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/05/2921:00PR Newswire (US)Audentes Therapeutics to Present at the Jefferies 2018 Global Healthcare ConferenceNASDAQ:BOLDBoundless Bio Inc
2018/05/2407:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/05/1700:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2018/05/1700:30PR Newswire (US)Audentes Announces Continuing Positive Data from First Dose Cohort of ASPIRO, a Phase 1/2 Clinical Trial of AT132 in Patients...NASDAQ:BOLDBoundless Bio Inc
2018/05/1105:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BOLDBoundless Bio Inc
2018/05/1005:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2018/05/1005:01PR Newswire (US)Audentes Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate UpdateNASDAQ:BOLDBoundless Bio Inc
2018/05/0921:00PR Newswire (US)Audentes Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference 2018NASDAQ:BOLDBoundless Bio Inc
2018/05/0821:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2018/05/0821:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2018/05/0821:00PR Newswire (US)Audentes Therapeutics Announces the Promotion of Natalie Holles to President and Chief Operating OfficerNASDAQ:BOLDBoundless Bio Inc
 검색 관련기사 보기:NASDAQ:BOLD

최근 히스토리

NASDAQ
NVDA
NVIDIA
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BASFY
BASF (QX)
NYSE
VZ
Verizon Communications
COIN
BTCUSD
Bitcoin
COIN
SOLUSD
Solana
NYSE
KO
Coca Cola
COIN
ETHUSD
Ethereum
USOTC
RHHBY
Roche (QX)
FX
USDGBP
US Dollar vs Sterling
CCOM
US500
US 500
CCOM
SILVER
SILVER
NYSE
MRK
Merck
NYSE
MCD
McDonalds
NASDAQ
AMZN
Amazon.com
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유